Pelago Bioscience is a Swedish specialized CRO focused on cellular target engagement. Their proprietary CETSA® technology allows for efficient assessment of drug-target interactions in live cells. This approach accelerates drug discovery by providing early insights and confidence in decision-making.
Assess cellular target engagement in drug discovery; Validate drug-target interactions in live cells; Optimize lead compounds for better efficacy; Conduct preclinical studies for drug candidates; Discover biomarkers for therapeutic targets.